Causes of Elevated Systemic Vascular Resistance (SVR)
Elevated SVR results from pathophysiological states that increase arterial vasoconstriction, with the most common causes being hypertension (particularly primary aldosteronism and renovascular hypertension), sympathetic nervous system activation, endothelial dysfunction, and hypothyroidism.
Primary Pathophysiological Mechanisms
Hypertension-Related Causes
Primary aldosteronism is a critical cause of elevated SVR that must be actively screened for in hypertensive patients. Contrary to traditional teaching, aldosterone initiates hypertension by amplifying salt-induced increases in SVR rather than by increasing cardiac output 1. The mechanism involves aldosterone promoting vascular resistance increases while simultaneously decreasing cardiac output when salt intake is elevated 1. Screen for this condition using the aldosterone-renin ratio (ARR) in patients with resistant hypertension, particularly those with hypokalemia 2.
Renovascular hypertension causes elevated SVR through activation of the renin-angiotensin-aldosterone system (RAAS) when renal artery stenosis decreases renal perfusion pressure 2. Major causes include atherosclerosis and fibromuscular dysplasia, with the latter particularly affecting younger women and children 2. Very elevated renin levels raise suspicion for this diagnosis 2.
Autonomic and Sympathetic Dysfunction
Sympathetic nervous system overactivation directly increases SVR through multiple mechanisms:
- Non-esterified fatty acids (NEFAs) acutely raise SVR via central sympathetic activation, increasing muscle sympathetic nerve activity by 65% and causing concomitant increases in blood pressure and vascular resistance 3
- Obstructive sleep apnea syndrome (OSAS) is present in up to 60% of patients with resistant hypertension and causes elevated SVR through sympathetic activation 2. Suspect OSAS in patients with non-dipping or reverse-dipping blood pressure patterns, especially if obese 2
Endothelial Dysfunction
Impaired endothelial function contributes significantly to elevated SVR. Patients with Fontan circulation demonstrate both increased muscle sympathetic nerve activity (40 vs 27 bursts per 100 heartbeats in controls) and decreased endothelial function, both contributing to their elevated SVR 4. This represents a common final pathway where multiple conditions converge.
Metabolic and Endocrine Causes
Hypothyroidism causes elevated SVR through reduced cardiac function and compensatory vasoconstriction 5. Even subclinical hypothyroidism results in 13-20% increases in SVR compared to euthyroid states 5. The severity of thyroid dysfunction correlates directly with the degree of SVR elevation—the lower the thyroid function, the higher the SVR 5. Levothyroxine treatment reverses these changes, reducing SVR by 13-20% 5.
Hemodynamic Considerations
Postural changes can unmask SVR abnormalities. In postural tachycardia syndrome (POTS), all variants demonstrate decreased cardiac output, decreased central blood volume, and increased SVR during orthostasis 6. Head-up tilt induces greater reductions in cardiac output in patients with vascular dysfunction, with compensatory SVR increases 4.
Clinical Pitfalls
Do not assume elevated blood pressure alone explains elevated SVR. The ratio of systolic blood pressure to left ventricular outflow tract velocity time integral (eSVR) correlates more closely with cardiovascular outcomes than blood pressure measurements alone 7. Patients with persistently elevated eSVR have the worst cardiovascular outcomes 7.
Recognize that significant ejection fraction variations often reflect SVR changes rather than intrinsic contractility problems 8. Longitudinal EF changes inversely correlate with concomitant SVR changes (p < 0.001), particularly in populations with hypertension and obesity 8.
Diagnostic Approach
When evaluating elevated SVR:
- Measure blood pressure properly using 24-hour ambulatory monitoring to identify non-dipping patterns suggesting OSAS 2
- Screen for primary aldosteronism with ARR in resistant hypertension, stopping interfering medications (beta-blockers, diuretics, ACE inhibitors, ARBs) when feasible 2
- Assess for renovascular disease using renal artery Doppler ultrasound or CT/MR angiography when renin is markedly elevated 2
- Evaluate thyroid function with TSH and free T4, as even subclinical hypothyroidism significantly elevates SVR 5
- Consider polysomnography for OSAS screening in resistant hypertension or abnormal blood pressure dipping patterns 2